/Companies

Paradoximmuno

Founded 2019 · 11 employees on LinkedIn · 3 known investors

Find your way into Paradoximmuno

Sign up to see every warm intro you have to Paradoximmuno

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Paradoximmuno team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Paradox Immuno develops a platform for discovering therapies targeting protein misfolding diseases, leveraging proprietary research and lead identification technology to address rare conditions with no existing treatments.

Founders & leadership

Paradoximmuno was founded in 2019 by Yulong Sun, PhD.

YSYulong Sun, PhD
Yulong Sun, PhDCo-Founder

Investors · 3

Frequently asked questions

What does Paradoximmuno do?
Paradox Immuno develops a platform for discovering therapies targeting protein misfolding diseases, leveraging proprietary research and lead identification technology to address rare conditions with no existing treatments.
Who founded Paradoximmuno?
Paradoximmuno was founded by Yulong Sun, PhD in 2019.
Who are Paradoximmuno's investors?
Paradoximmuno's investors include Beresford Ventures, Ontario Centre of Innovation, Ontario Centre of Innovation programs.